American International Group, Inc. Cyteir Therapeutics, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.62 - $4.4 $15,022 - $40,801	-9,273 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.39 - $10.51 $16,373 - $50,763	4,830 Added 108.71%	9,273 $35,000
Q4 2021 Feb 11, 2022	SELL	$9.83 - $19.21 $1,307 - $2,554	-133 Reduced 2.91%	4,443 $51,000
Q3 2021 Nov 12, 2021	BUY	$14.57 - $21.86 $66,672 - $100,031	4,576 New	4,576 $80,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.